The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the ...

After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...

Americans who took proton pump inhibitors, or PPIs, for four-and-a-half years or longer were 33% more likely to develop ...

Pantoprazole can interact with many medications, including drugs that treat cancer, iron supplements, and HIV medicines, ...

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) </ ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...

Regularly taking this tablet could increase the risk of developing the degenerative disease by as much as a third.

Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD: Braintree, Massachusetts Friday, April 25, 2025, 18:00 Hrs [IST] Braintree Laborator ...